DNDi welcomes Malaysia’s move to secure access to more affordable treatments for hepatitis C

[Kuala Lumpur, Geneva20 September 2017]
Malaysia has issued a “government use” licence enabling access to more affordable versions of an expensive and patented medicine to treat hepatitis C. This landmark decision should help the more than 400,000 people living with hepatitis C in Malaysia access sofosbuvir, and could have important repercussions in the global effort to secure access to expensive treatments for this viral disease.
[Bahasa] [Español] [Português]

DNDi sambut baik usaha Malaysia untuk mendapatkan akses kepada kos rawatan lebih rendah untuk hepatitis C

[Kuala Lumpur, Geneva20 September 2017]
Malaysia telah mengeluarkan lesen “kegunaan kerajaan” yang membolehkan akses kepada ubat yang mahal dan berpaten pada harga yang lebih rendah untuk merawat hepatitis C. Keputusan penting ini pastinya akan membantu lebih daripada 400,000 orang penghidap hepatitis C di Malaysia mendapatkan ubat sofosbuvir dan akan memberi kesan yang signifikan dalam usaha global untuk mendapat akses kepada rawatan yang mahal bagi penyakit yang disebabkan virus ini.“Kerajaan Malaysia tidak dapat menyediakan akses kepada rejimen rawatan yang mampu dibayar oleh masyarakat umum kerana harga sofosbuvir yang sangat mahal di Malaysia,” kata YB Datuk Seri Dr S. Subramaniam, Menteri Kesihatan Malaysia.
[English] [Español] [Português]

COR-NTD – 2017

November 3-4, 2017
Baltimore, Maryland
Colin Forysyth, Epidemiologist, DNDi North America, presented on Chagas disease.

World Hepatitis Summit

November 1-3, 2017
São Paulo, Brazil
Francisco Viegas Neves da Silva, Regional Policy Advocacy Consultant, DNDi Latin America, presented on the DNDi strategy on access to hepatitis C treatment.

Fair Pricing Forum 2017

May 10-11, 2017
Amsterdam, The Netherlands
Organized by the World Health Organization in collaboration with the Dutch Ministry of Health, the Fair Pricing Forum was held to discuss options for a fairer pricing system, that is sustainable for both health systems and innovation challenges to access and how to move forward.

DNDi participated in the event.

2016 in Review

Our staff, partners, and stakeholders share their highlights from 2016.